Acadian Asset Management LLC Takes Position in Encompass Health Co. (NYSE:EHC)

Acadian Asset Management LLC acquired a new position in shares of Encompass Health Co. (NYSE:EHC) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 10,531 shares of the company’s stock, valued at approximately $901,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Charles Schwab Investment Management Inc. boosted its position in shares of Encompass Health by 2.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 631,816 shares of the company’s stock worth $42,155,000 after purchasing an additional 12,396 shares in the last quarter. Principal Securities Inc. bought a new position in Encompass Health during the fourth quarter worth about $25,000. QRG Capital Management Inc. grew its stake in Encompass Health by 10.4% in the fourth quarter. QRG Capital Management Inc. now owns 6,271 shares of the company’s stock valued at $418,000 after acquiring an additional 593 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of Encompass Health by 12.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,764,092 shares of the company’s stock worth $117,703,000 after acquiring an additional 190,860 shares in the last quarter. Finally, Vanguard Personalized Indexing Management LLC increased its holdings in shares of Encompass Health by 58.6% in the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 10,682 shares of the company’s stock worth $713,000 after acquiring an additional 3,948 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Encompass Health Trading Up 0.4 %

NYSE EHC opened at $93.59 on Tuesday. Encompass Health Co. has a 12 month low of $57.55 and a 12 month high of $94.59. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.08. The stock has a 50 day moving average of $89.50 and a 200-day moving average of $84.90. The company has a market cap of $9.42 billion, a PE ratio of 25.29, a PEG ratio of 1.39 and a beta of 0.88.

Encompass Health (NYSE:EHC) last issued its earnings results on Monday, August 5th. The company reported $1.11 earnings per share for the quarter, topping analysts’ consensus estimates of $1.01 by $0.10. The business had revenue of $1.30 billion for the quarter, compared to the consensus estimate of $1.30 billion. Encompass Health had a net margin of 7.88% and a return on equity of 17.83%. The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.95 earnings per share. On average, equities research analysts anticipate that Encompass Health Co. will post 4.18 EPS for the current fiscal year.

Encompass Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Tuesday, October 1st will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.73%. This is an increase from Encompass Health’s previous quarterly dividend of $0.15. The ex-dividend date is Tuesday, October 1st. Encompass Health’s payout ratio is presently 18.38%.

Insider Buying and Selling

In related news, CFO Douglas E. Coltharp sold 12,260 shares of the business’s stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $86.34, for a total transaction of $1,058,528.40. Following the transaction, the chief financial officer now directly owns 136,227 shares in the company, valued at $11,761,839.18. The sale was disclosed in a filing with the SEC, which is available through this link. 2.10% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on EHC shares. Leerink Partnrs upgraded Encompass Health to a “strong-buy” rating in a report on Wednesday, July 10th. Leerink Partners started coverage on Encompass Health in a report on Wednesday, July 10th. They issued an “outperform” rating and a $100.00 price target for the company. UBS Group increased their price target on Encompass Health from $96.00 to $100.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. Stephens restated an “overweight” rating and issued a $105.00 price target on shares of Encompass Health in a report on Tuesday, August 6th. Finally, Royal Bank of Canada increased their price target on Encompass Health from $83.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, May 22nd. Nine research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of $100.38.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.